Citation

Gohil K. P T 2014; 39(10): 684-694.

Copyright

(Copyright © 2014, MediMedia)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; insomnia; liver failure; suicidal ideation; depression; anxiety; behavior change; comorbidity; pregnancy; apoptosis; cell proliferation; neutropenia; hallucination; somnolence; signal transduction; nonhuman; placebo; food and drug administration; cardiomyopathy; seizure; diarrhea; pharmaceutical care; congestive heart failure; drug information; amnesia; hepatitis; hyperthyroidism; alanine aminotransferase; aspartate aminotransferase; liver toxicity; liver injury; drug approval; hypothyroidism; parasomnia; multiple sclerosis; pneumonia; idiopathic thrombocytopenic purpura; drug classification; Article; central depressant agent; cataplexy; intestine perforation; blood cell count; anaphylaxis; colitis; B cell lymphoma; autoimmune hepatitis; wakefulness; recommended drug dose; chronic lymphatic leukemia; rituximab; orexin A; respiratory function; abnormal thinking; epidermolysis; cell viability; injection site necrosis; chemokine receptor CXCR4; hypertransaminasemia; B lymphocyte receptor; chemokine receptor CXCR5; embryotoxicity; idelalisib; lymphocytoma; orexin B; peginterferon beta1a; suvorexant